Time of first diagnosis in liver cirrhosis: what has changed over time from etiology to stage of disease?
Authors:
- Zülal İsTemihanZIZülal İsTemihan
- Ahmet Oğuz ÇelikAÇAhmet Oğuz Çelik
- Arzu TaşATArzu Taş
- Dilek DenizDDDilek Deniz
- Çağrı MuratoğluÇMÇağrı Muratoğlu
- Kanan NuriyevKNKanan Nuriyev
- Sezen Genç UluçeçenSUSezen Genç Uluçeçen
- Aynura RustamzadeARAynura Rustamzade
- Gizem DağcıGDGizem Dağcı
- Mehmet Akif YağlıMYMehmet Akif Yağlı
- Bilger ÇavuşBÇBilger Çavuş
- Aslı Çifcibaşı ÖrmeciAÖAslı Çifcibaşı Örmeci
- 15 May 2026
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (4) , 479-486
Abstract
It was aimed to investigate the characteristics of cirrhosis etiology, stage at diagnosis, diagnostic methods, and complications with a 1-decade interval. The clinical and demographic characteristics of patients with cirrhosis at the time of diagnosis at a tertiary university hospital between 2005-2009 (first period) and 2019-2023 (second period) were retrospectively investigated. In total, 1311 patients were diagnosed with cirrhosis, of which 857 (65.4%) were men. Seven hundred and ninety-eight (60.9%) were diagnosed in the first period. Six hundred and ninety (52.6%) patients were decompensated at diagnosis. Child Turcotte Pugh score was more common in the second period. MELD-Na score was higher in the first period (p = 0.026). The presentation rate with decompensation was higher in the first period (p = 0.009). In the first period, 211 (26.4%), and in the second period, 134 (26.1%) patients were diagnosed in the emergency department. The others were diagnosed in the outpatient clinic. There was no difference in the conditions for diagnosing between periods (p = 0.898). The causes of cirrhosis were, in order, 22.6% HBV, 19.7% MASLD, 18.9% cryptogenic, 13.1% ALD, 10.1% HCV, 7.7% autoimmune liver diseases, 4% HDV, 2.1% other causes, and 1.8% genetic diseases. In the second period, the frequency of cirrhosis caused by viral etiologies decreased (p < 0.05), and the frequency of MASLD and ALD increased (p < 0.05). Over the past decade, viral factors in the etiology of cirrhosis have gradually decreased, MASLD and ALD have progressively increased. While patients were detected more in compensated states, a significant portion of patients are still diagnosed in the decompensated stage and in emergency clinics.Keywords
This publication has 28 references indexed in Scilit:
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology, 2024
- Burden of liver diseases in the worldJournal of Hepatology, 2019
- Changing Trends in Etiology‐Based and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United StatesHepatology, 2018
- Clinical states of cirrhosis and competing risksJournal of Hepatology, 2018
- Diabetes Is Associated with Clinical Decompensation Events in Patients with CirrhosisDigestive Diseases and Sciences, 2016
- Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B–related Hepatocellular CarcinomaClinical Gastroenterology and Hepatology, 2016
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §ΔHepatology, 2010
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2006
- Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis Relationship to CirrhosisGastroenterology, 1988